Latest Posts
About This Stock
More About This Stock
Read
Shares Of Vical Tumbled 43% After Reporting Failed Results In Herpes Vaccine
Article By:
Terry Chrisomalis
Tuesday, June 23, 2015 5:55 PM EDT
Shares of Vical (VICL) closed down 43% today after the company reported negative results in its Phase 1/2 trial in patients with Herpes.